Literature DB >> 10395261

A new accurate, rapid and cost-effective protocol for stroke-prevention screening.

G S Lavenson1.   

Abstract

The three immediate causes of stroke are cervical carotid artery disease, atrial fibrillation and hypertension. Recognition and appropriate management of these causes can prevent the majority of strokes they would have caused. The purpose of this study was to develop a new protocol for screening for these causes that is more accurate, rapid and cost effective than existing protocols. In this protocol, rather than relying on auscultation with a stethoscope, the carotid artery was screened with a newly developed and more accurate quick color image scan ultrasound technique and a lead 2 EKG rhythm strip was used to find atrial fibrillation. The focus in this protocol was on the rapid detection of the three immediate causes of stroke and did not include a lengthy questionnaire or long counseling. A cholesterol determination was not included and there was little or no cost to the participants. In stroke screening trials of the new protocol at two institutions, 176 participants were screened at a rate of one every 2.7 minutes. There were 26 with > 50% carotid stenosis, 16 with previously unknown cardiac arrhythmias and 104 had hypertension. It was concluded that this protocol provides an accurate, rapid and cost-effective means of screening for the three immediate causes of stroke and can on broad application result in significant stroke reduction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10395261     DOI: 10.1016/s0967-2109(98)00083-0

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  2 in total

1.  Noninvasive vascular testing--a 35-year reflection.

Authors:  George S Lavenson
Journal:  World J Surg       Date:  2005       Impact factor: 3.352

2.  Carotid stenosis: what is the high-risk population?

Authors:  Jong Hun Park; Alvaro Razuk; Paulo Fernandes Saad; Gustavo José Politzer Telles; Walter Khegan Karakhanian; Alexandre Fioranelli; Alessandra Caivano Rodrigues; Giuliano Giova Volpiani; Pollyanna Campos; Roberto Massayoshi Yamada; Valter Castelli; Roberto Augusto Caffaro
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.